Consumer Lawyers

Archive for November, 2011|Monthly archive page

Children’s Animal Slippers Recalled Due to Choking Hazard; Sold Exclusively at Family Dollar Stores

In Uncategorized on November 19, 2011 at 8:02 pm

The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product.

Name of Product: Kidgets® Animal Sock Top Slippers

Units: About 160,000

Distributor/Retailer: Family Dollar Services Inc., of Matthews, N.C.

Importer: BCNY International Inc., of Hicksville, N.Y.

Hazard: The animal’s eyes can detach from the slippers, posing a choking hazard to young children.

Incidents/Injuries: Family Dollar has received one report of the eyes detaching from the slippers. No injuries have been reported.

Description: The recalled children’s slippers have brown or tan dog faces, yellow duck faces and tan lion faces. The name “Kidgets” and the size appear inside the slippers on the soles. “FD9619108020690611” is printed inside the slippers on the side.

Sold exclusively at: Family Dollar stores nationwide from September 2011 through October 2011 for about $5.

Manufactured in: China

Remedy: Consumers should immediately take the slippers away from children and return them to any Family Dollar store for a full refund.

Customer Contact: For additional information, contact Family Dollar at (800) 547-0359 between 8 a.m. and 5 p.m. ET Monday through Friday, or visit the firm’s website at http://www.familydollar.com

Family Dollar, Munising

Image by wachovia_138 via Flickr

Enhanced by Zemanta

Carefusion Initiates Class I Recall Of EnVe Ventilators

In Uncategorized on November 19, 2011 at 8:00 pm

 CareFusion (NYSE: CFN), a leading global medical device company, issued the following update regarding its recall of 128 EnVe™ ventilators affecting 29 customers. The FDA has classified this action as a Class I recall.

The voluntary recall only affects EnVe ventilators manufactured between December 2010 and May 2011 and therefore, has no affect on the company’s current product production or shipping processes.

On September 12, the company sent an urgent Medical Device Recall Notification to customers stating the identified potential risks associated with the EnVe ventilators. The issues include: a potential delay in resuming ventilation after reconnection; a potential automatic reset; and a potential for disconnection upon transport. Failure to adequately ventilate may lead to hypoxia or hypercarbia, which may result in serious neurological injury or death. A Class I recall is defined as a reasonable probability of serious adverse health consequences or death associated with use of the defective units.

In the notification letter, customers were provided serial numbers of affected devices. This information is available athttp://www.carefusion.com/customer-support/alerts-notices/medical-device-recall-enve-ventilator.aspx.

CareFusion is conducting a field corrective action to update the hardware and software on affected ventilators. The company had determined the root cause for each issue and is committed to updating each device in a timely manner with minimal disruption to our customers.

Instructions to customers
Customer inquiries related to this action should be addressed to CareFusion Technical Support at 800-554-8933.

FDA Recalls Uprizing 2.0 Because the Product Contains Superdrol, Which is a Synthetic Steroid, Making it an Unapproved New Drug

In Uncategorized on November 19, 2011 at 1:36 pm

Superior Metabolic Technologies Inc of Marietta, Georgia is voluntarily recalling all lots of the testosterone booster Uprizing 2.0 because tests have shown the product appears to contain superdrol, a synthetic steroid, making it an unapproved new drug.

On August 5 the FDA made Superior Metabolic Technologies Inc aware that Uprizing 2.0 contains superdrol which is banned by the FDA. This led to the recall of the product.

Acute liver injury is known to be a possible harmful effect of using products containing synthetic anabolic steroids. In addition, use of synthetic anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher prediction to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.

Uprizing 2.0 was distributed through retail health food stores in Alabama, Arizona, California, Georgia, Mississippi, New Jersey, South Carolina, and Texas.

Uprizing 2.0 comes in a black plastic bottle with a black, red, and silver label and contains 90 capsules. The SMT logo is center top on the bottle.

Consumers who purchased Uprizing 2.0 are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 1-888-445-3230, from 10 AM to 6 PM EST Monday through Friday.

Adverse reactions or quality problems experienced with the use of these products may be reported to Superior Metabolic Technologies Inc toll free at 1-888-445-3230 or to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

http://www.ageorgialawyer.com, http://www.markzamora.com

:Original raster version: :Image:Food and Drug...

Image via Wikipedia

Enhanced by Zemanta

Insight Pharmaceuticals Issues A Voluntary Nationwide Recall Of “Nostrilla Nasal Decongestant” Due To Bacterial Contamination

In Uncategorized on November 19, 2011 at 1:33 pm

Here is news from the FDA site:

 

Insight Pharmaceuticals, LLC of Langhorne, Pa., is recalling one lot (34,092 bottles) of Nostrilla Nasal Decongestant nasal spray to the consumer level, because it may contain the bacteria Burkholderia cepacia.

Burkholderia cepacia may cause serious infection in individuals with a compromised immune system or chronic lung condition (i.e. cystic fibrosis).  However, the possibility of infection is remote in healthy individuals.

Nostrilla Nasal Decongestant, lot #11G075, UPC Code 6373673005, was distributed nationwide through normal retail outlets and pharmacies. The product comes in a 1/2 ounce, plastic bottle marked with lot #11G075 on the label and with an expiration date of 05/2014 stamped on the side. No illnesses have been reported to date in connection with this problem.

The recall was initiated following internal investigations which determined the potential presence of a microbial contaminant that exceeds the product specifications and may consequently result in a subpar product. This contaminant has been found sporadically throughout only the respective manufacturing lot, #11G075.

Consumers who have purchased “Nostrilla Decongestant, lot #11G075” are urged to return the product and contact the company at 1-877-546-9059 Monday through Friday from 9 am-5 pm EST time zone.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Scanning Electron Micrograph of Burkholderia c...

Image via Wikipedia

Enhanced by Zemanta

Avaiara Cooper Lens Recall across the USA and Georgia

In Uncategorized on November 18, 2011 at 8:24 pm
One-day disposable blue color contact lens in ...

Image via Wikipedia

Nearly 5 million contact lenses shipped to consumers are being recalled by CooperVision Inc. in an expanded action that includes a second Avaira brand that may be contaminated with silicone oil residue and linked to blurred vision, eye injuries and severe pain.

CooperVision Inc. officials on Tuesday added Avaira Sphere contact lenses to an August recall of Avaira Toric lenses because certain lots failed to meet quality standards because of the oil residue, according to a press release from the company’s Pleasanton, Calif., office. Denise Powell, a company spokeswoman, said the line produced 6.6 million Avaira Sphere lenses affected by the recall, but 4.9 million were actually shipped.

The move comes after the federal Food and Drug Administration issued a Class I warning about the products and pressured the company last month to increase public notice about the recall of nearly 780,000 Avaira Toric lenses. Class I recalls are the most serious kind and involve problems in which there is a reasonable chance of serious adverse health consequences or death.

As of late October, the FDA had received at least 40 reports of problems associated with various CooperVision contact lenses, agency records show. At least 15 mentioned Avaira Toric and at least two mentioned Avaira Sphere, according to data shared by Phyllis Entis, who maintains the eFoodAlert blog. An FDA official was not available to discuss the new recall Tuesday.

Dozens of Avaira Toric users reported problems ranging from hazy vision and pain to severe injuries, including torn corneas, which required emergency medical treatment. Company officials were accused of issuing a “stealth recall” in August that left many consumers unaware of the problem.

 

http://www.markzamora.com 404-451-7781

Company officials noted that no product lines other than Avaira Toric and Avaira Sphere use silicone oil to manufacture the products. The firm expects to set aside a reserve of $9 million for the costs of the expanded recall. All told, the company expects to spend $23.2 million on the Avaira recalls, according to the press release.

Consumers with problems or questions related to the recalls should contact the company at 1-855-526-6737. The firm says it has reached out to affected consumers to ensure their safety.

Defective Contact Lens Lawsuit

If you or a loved one have suffered or been injured by defective CooperVision Avaira Contact Lenses you may be entitled to compensation and justice. Call Us 404-451-7781

Enhanced by Zemanta

Keime Inc dba Barry’s Vitamins Conducts a Nationwide Voluntary Recall of Virility Max Dietary Supplement

In Uncategorized on November 18, 2011 at 8:17 pm

Keime Incorporated announced today that it is conducting a voluntary recall of one lot of the companies dietary supplement product sold under the following name:  Virility Max.  The company has been informed by representatives of the FDA that lab analysis by FDA for Lot 10090571, found the product contained sulfoaildenafil, an analog of sildenafil. Sildenafil is an active ingredient of an FDA approved drug for erectile dysfunction (ED), making Virility Max an unapproved drug.

 

The active drug ingredient is not listed on the product label.  The undeclared ingredient may interact with nitrates found in some prescription drugs, such as nitroglycerin and may lower blood pressure to dangerous levels.  Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.  Additionally, the product may cause side effects, such as headaches and flushing.
Virility Max is used for sexual enhancement.  It is distributed in 10 count, white plastic bottles to retail customers in the South Florida area.

No illnesses have been reported to the company to date in connection with this product.
Customers who have this product in their possession should stop using it immediately and contact their physician if they have experienced any problems that may be related to taking this produc

Enhanced by Zemanta

Hello world!

In Uncategorized on November 18, 2011 at 8:16 pm

Welcome to WordPress.com. After you read this, you should delete and write your own post, with a new title above. Or hit Add New on the left (of the admin dashboard) to start a fresh post.

Here are some suggestions for your first post.

  1. You can find new ideas for what to blog about by reading the Daily Post.
  2. Add PressThis to your browser. It creates a new blog post for you about any interesting  page you read on the web.
  3. Make some changes to this page, and then hit preview on the right. You can always preview any post or edit it before you share it to the world.